Company research
Zepp Health Corp
CIK 1720446Updated Sep 24, 2026
SecurityZEPP · NYSE · adr
Name history
Huami Corp · through Feb 25, 2021
ZEPP price & chart
Loading TradingView…
NYSE:ZEPP on TradingView ↗Financials
FY 2025 · USDSource
Source
Source
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| ASSETS | ||||
| AssetsUSD | 564,836,000Source | 528,593,000Source | 635,519,000Source | 763,735,000Source |
| Property, Plant and Equipment, NetUSD | 5,662,000Source | 6,898,000Source | 8,929,000Source | 14,586,000Source |
| GoodwillUSD | 9,581,000Source | 9,581,000Source | 9,581,000Source | 9,581,000Source |
| Intangible Assets, Net (Excluding Goodwill)USD | 13,611,000Source | 7,091,000Source | 9,868,000Source | 17,877,000Source |
| Current assets: | ||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 57,046,000Source | 91,069,000Source | 133,669,000Source | 128,550,000Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 66,908,000Source | 62,965,000Source | 60,727,000Source | 98,896,000Source |
| Inventory, NetUSD | 72,756,000Source | 56,789,000Source | 84,887,000Source | 148,165,000Source |
| Assets, CurrentUSD | 293,525,000Source | 251,564,000Source | 316,732,000Source | 428,948,000Source |
| Prepaid Expense and Other Assets, CurrentUSD | 34,263,000Source | 17,415,000Source | 16,891,000Source | 15,694,000Source |
| Operating Lease, Right-of-Use AssetUSD | 1,958,000Source | 3,458,000Source | 6,819,000Source | 9,507,000Source |
| Other Assets, NoncurrentUSD | 3,718,000Source | 4,607,000Source | 9,698,000Source | 7,306,000Source |
| LIABILITIES AND EQUITY | ||||
| LiabilitiesUSD | 350,303,000Source | 275,865,000Source | 282,767,000Source | 374,459,000Source |
| Stockholders’ equity: | ||||
| Additional Paid in CapitalUSD | 280,676,000Source | 278,116,000Source | 246,564,000Source | 245,154,000Source |
| Retained Earnings (Accumulated Deficit)USD | -11,450,000Source | 28,618,000Source | 102,921,000Source | 136,700,000Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | -38,566,000Source | -40,178,000Source | 13,566,000Source | 15,339,000Source |
| Stockholders' Equity Attributable to ParentUSD | 214,533,000Source | 251,589,000Source | 351,071,000Source | 387,478,000Source |
| Liabilities and EquityUSD | 564,836,000Source | 528,593,000Source | 635,519,000Source | 763,735,000Source |
| Current liabilities: | ||||
| Liabilities, CurrentUSD | 286,844,000Source | 195,367,000Source | 155,111,000Source | 241,933,000Source |
| Operating Lease, Liability, CurrentUSD | 930,000Source | 1,357,000Source | 27,500,000Source | 42,320,000Source |
| Accounts Payable, CurrentUSD | 80,768,000Source | 51,077,000Source | 37,286,000Source | 66,198,000Source |
| Operating Lease, Liability, NoncurrentUSD | 1,102,000Source | 2,007,000Source | 3,197,000Source | 4,595,000Source |
| Deferred Income Tax Liabilities, NetUSD | 2,673,000Source | 3,117,000Source | 4,169,000Source | 5,155,000Source |
| Other Liabilities, NoncurrentUSD | 209,000Source | 133,000Source | 270,000Source | 23,575,000Source |
| Stockholders' Equity Attributable to Noncontrolling InterestUSD | — | 1,139,000Source | 1,681,000Source | 1,798,000Source |
| Additional Financial Items | ||||
| Accrued Liabilities, CurrentUSD | 757,000Source | 123,000Source | 5,906,000Source | 6,703,000Source |
| Deferred Revenue, CurrentUSD | 4,664,000Source | 4,946,000Source | 53,980,000Source | 61,164,000Source |
| Dividends PayableCNY | — | — | 0Source | — |
| Long-term DebtUSD | 59,475,000Source | 75,241,000Source | 120,020,000Source | 99,201,000Source |
| Short-term InvestmentsUSD | — | 997,000Source | 5,153,000Source | 4,975,000Source |
cash flow · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | -40,068,000Source | -75,808,000Source | -29,942,000Source | -41,901,000Source |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||
| Depreciation, Depletion and AmortizationUSD | 4,535,000Source | 5,017,000Source | 7,669,000Source | 8,498,000Source |
| Share-based Payment Arrangement, Noncash ExpenseUSD | 2,492,000Source | 4,778,000Source | 8,408,000Source | 7,120,000Source |
| Changes in operating assets and liabilities: | ||||
| Increase (Decrease) in Accounts ReceivableUSD | 8,331,000Source | 5,082,000Source | -35,345,000Source | 21,120,000Source |
| Increase (Decrease) in InventoriesUSD | 22,092,000Source | -5,555,000Source | -51,770,000Source | -27,236,000Source |
| Increase (Decrease) in Accounts PayableUSD | 28,295,000Source | 14,811,000Source | -27,023,000Source | -132,036,000Source |
| Deferred Income Tax Expense (Benefit)USD | 2,238,000Source | 13,445,000Source | -18,725,000Source | -66,254,000Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | -25,692,000Source | -24,392,000Source | 42,067,000Source | -114,199,000Source |
| Cash flows from investing activities: | ||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | 1,480,000Source | -1,579,000Source | 7,706,000Source | -6,127,000Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | 516,000Source | 1,403,000Source | 1,592,000Source | 1,180,000Source |
| Cash flows from financing activities: | ||||
| Payments for Repurchase of Common StockUSD | 1,238,000Source | 2,278,000Source | 2,502,000Source | 7,716,000Source |
| Net Cash Provided by (Used in) Financing ActivitiesUSD | 24,835,000Source | 477,000Source | -41,555,000Source | 41,928,000Source |
| Dividends paid | — | — | — | — |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 112,933,000Source | 110,735,000Source | 140,469,000Source | 141,121,000Source |
| Supplemental disclosure of cash flow information: | ||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | 1,243,000Source | 89,000Source | 6,248,000Source | 8,097,000Source |
| Additional Financial Items | ||||
| Share-based Payment Arrangement, ExpenseUSD | 2,492,000Source | 4,778,000Source | 59,698,000Source | 49,107,000Source |
| Amortization of Intangible AssetsUSD | 2,825,000Source | 2,446,000Source | 17,661,000Source | 17,212,000Source |
| Debt and Equity Securities, Unrealized Gain (Loss)USD | 76,000Source | 2,011,000Source | 176,000Source | 7,513,000Source |
| DepreciationUSD | 1,710,000Source | 2,571,000Source | 36,791,000Source | 41,406,000Source |
| Dividends PayableCNY | — | — | 0Source | — |
| Equity Method Investment, Other than Temporary ImpairmentUSD | 0Source | 0Source | 2,263,000Source | 0Source |
| Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual AmountUSD | 0Source | 7,260,000Source | 0Source | 13,858,000Source |
| Gain (Loss) on Disposition of Property Plant EquipmentUSD | -21,000Source | 56,000Source | -53,000Source | 277,000Source |
| General and Administrative ExpenseUSD | 29,273,000Source | 24,854,000Source | 26,551,000Source | 34,207,000Source |
| GoodwillUSD | 9,581,000Source | 9,581,000Source | 9,581,000Source | 9,581,000Source |
| Goodwill, Impairment LossUSD | 0Source | 0Source | 0Source | 0Source |
| Impairment of Intangible Assets (Excluding Goodwill)USD | 0Source | 0Source | 8,036,000Source | 0Source |
| Impairment of Intangible Assets, Finite-livedUSD | 0Source | 0Source | 1,132,000Source | 0Source |
| Income (Loss) from Equity Method InvestmentsUSD | -2,068,000Source | -4,211,000Source | 1,181,000Source | 2,560,000Source |
| Income Tax Expense (Benefit)USD | 2,537,000Source | 13,693,000Source | -2,228,000Source | -9,551,000Source |
| InterestExpenseNonoperatingUSD | 5,697,000Source | 5,552,000Source | — | — |
| Net Income (Loss) Attributable to ParentUSD | -40,068,000Source | -75,733,000Source | -29,877,000Source | -41,801,000Source |
| Net Income (Loss) Attributable to Noncontrolling InterestUSD | — | -75,000Source | -65,000Source | -100,000Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | -40,068,000Source | -75,733,000Source | -29,877,000Source | -41,801,000Source |
| Operating ExpensesUSD | 128,420,000Source | 117,484,000Source | 121,816,000Source | 175,921,000Source |
| Realized Investment Gains (Losses)USD | — | — | 109,000Source | 87,000Source |
| Unrealized Gain (Loss) on InvestmentsCNY | — | — | 0Source | 0Source |
income statement · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Total RevenueUSD | 258,897,000Source | 182,603,000Source | 2,495,322,000Source | 4,142,862,000Source |
| Cost of RevenueUSD | 159,707,000Source | 112,369,000Source | 258,813,000Source | 484,218,000Source |
| Operating Income (Loss)USD | -29,230,000Source | -47,250,000Source | -29,170,000Source | -59,480,000Source |
| Income Tax Expense (Benefit)USD | 2,537,000Source | 13,693,000Source | -2,228,000Source | -9,551,000Source |
| Net Income (Loss) Attributable to Noncontrolling InterestUSD | — | -75,000Source | -65,000Source | -100,000Source |
| Net Income (Loss) Attributable to ParentUSD | -40,068,000Source | -75,733,000Source | -29,877,000Source | -41,801,000Source |
| Earnings Per Share, BasicUSD per share | -0.16Source | -0.29Source | -0.12Source | -0.17Source |
| Earnings Per Share, DilutedUSD per share | -0.16Source | -0.29Source | -0.12Source | -0.17Source |
| Weighted Average Number of Shares Outstanding, Basicshares | 254,431,492Source | 258,876,120Source | 243,135,964Source | 246,283,328Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | 254,431,492Source | 258,876,120Source | 243,135,964Source | 246,283,328Source |
| Interest Expense (non-operating)USD | 5,697,000Source | 5,552,000Source | — | — |
| Additional Financial Items | ||||
| Amortization of Intangible AssetsUSD | 2,825,000Source | 2,446,000Source | 17,661,000Source | 17,212,000Source |
| Current Income Tax Expense (Benefit)USD | 299,000Source | 248,000Source | 2,903,000Source | 379,000Source |
| Debt and Equity Securities, Unrealized Gain (Loss)USD | 76,000Source | 2,011,000Source | 176,000Source | 7,513,000Source |
| Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual AmountUSD | 0Source | 7,260,000Source | 0Source | 13,858,000Source |
| General and Administrative ExpenseUSD | 29,273,000Source | 24,854,000Source | 26,551,000Source | 34,207,000Source |
| Goodwill, Impairment LossUSD | 0Source | 0Source | 0Source | 0Source |
| Gross ProfitUSD | 99,190,000Source | 70,234,000Source | 92,646,000Source | 116,441,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, DomesticUSD | -18,110,000Source | — | — | — |
| Income (Loss) from Equity Method InvestmentsUSD | -2,068,000Source | -4,211,000Source | 1,181,000Source | 2,560,000Source |
| Interest and Other IncomeUSD | 1,526,000Source | 3,672,000Source | 3,087,000Source | 1,788,000Source |
| Interest ExpenseUSD | — | — | 6,719,000Source | 8,264,000Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | -40,068,000Source | -75,733,000Source | -29,877,000Source | -41,801,000Source |
| Operating ExpensesUSD | 128,420,000Source | 117,484,000Source | 121,816,000Source | 175,921,000Source |
| Other IncomeUSD | 56,000Source | -656,000Source | -515,000Source | 6,353,000Source |
| Realized Investment Gains (Losses)USD | — | — | 109,000Source | 87,000Source |
| Research and Development ExpenseUSD | 45,318,000Source | 46,159,000Source | 50,960,000Source | 74,976,000Source |
| Selling and Marketing ExpenseUSD | 53,829,000Source | 46,471,000Source | 44,305,000Source | 66,738,000Source |